Market Closed

MBOT
Microbot Medical
$ 0.9787
-4.98%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Microbot Medical News

Latest Microbot Medical Stock News & MBOT Headlines

Microbot Medical Inc. (MBOT) Reports Q3 Loss, Misses Revenue Estimates
a day ago | zacks.com
Microbot Medical® Strengthens IP Portfolio as it Continues to Establish Infrastructure to Support Future Commercialization Expansion
10 days ago | globenewswire.com
Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System
19 days ago | globenewswire.com
Microbot Medical® Attending Key Medical Conference to Engage with Decision-makers as it Continues to Expand Presence Across the U.S.
23 days ago | globenewswire.com
Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
a month ago | globenewswire.com
Microbot Medical® Highlights Growth Strategy
2 months ago | globenewswire.com
Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates
3 months ago | zacks.com
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
4 months ago | globenewswire.com
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026
4 months ago | globenewswire.com
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
5 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

MBOT
Microbot Medical
$ 0.9787
-4.98%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago